Cargando…

Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements

BACKGROUND: Twenty-four-hour and nighttime blood pressure (BP) levels are more strongly associated with cardiovascular risk than office or daytime BP measurements. However, it remains undocumented which of the office and ambulatory BP measurements have the strongest association and predictive inform...

Descripción completa

Detalles Bibliográficos
Autores principales: Melgarejo, Jesus D., Maestre, Gladys E., Gutierrez, Jose, Thijs, Lutgarde, Mena, Luis J., Gaona, Ciro, Leendertz, Reinier, Lee, Joseph H., Chávez, Carlos A., Calmon, Gustavo, Silva, Egle, Wei, Dongmei, Terwilliger, Joseph D., Vanassche, Thomas, Janssens, Stefan, Verhamme, Peter, Bos, Daniel, Zhang, Zhen-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330602/
https://www.ncbi.nlm.nih.gov/pubmed/35911921
http://dx.doi.org/10.3389/fneur.2022.908260
_version_ 1784758202202587136
author Melgarejo, Jesus D.
Maestre, Gladys E.
Gutierrez, Jose
Thijs, Lutgarde
Mena, Luis J.
Gaona, Ciro
Leendertz, Reinier
Lee, Joseph H.
Chávez, Carlos A.
Calmon, Gustavo
Silva, Egle
Wei, Dongmei
Terwilliger, Joseph D.
Vanassche, Thomas
Janssens, Stefan
Verhamme, Peter
Bos, Daniel
Zhang, Zhen-Yu
author_facet Melgarejo, Jesus D.
Maestre, Gladys E.
Gutierrez, Jose
Thijs, Lutgarde
Mena, Luis J.
Gaona, Ciro
Leendertz, Reinier
Lee, Joseph H.
Chávez, Carlos A.
Calmon, Gustavo
Silva, Egle
Wei, Dongmei
Terwilliger, Joseph D.
Vanassche, Thomas
Janssens, Stefan
Verhamme, Peter
Bos, Daniel
Zhang, Zhen-Yu
author_sort Melgarejo, Jesus D.
collection PubMed
description BACKGROUND: Twenty-four-hour and nighttime blood pressure (BP) levels are more strongly associated with cardiovascular risk than office or daytime BP measurements. However, it remains undocumented which of the office and ambulatory BP measurements have the strongest association and predictive information in relation to the presence of type I, or arteriolosclerosis type, cerebral small vessel diseases (CSVD). METHODS: A subset of 429 participants from the Maracaibo Aging Study [aged ≥40 years (women, 73.7%; mean age, 59.3 years)] underwent baseline brain magnetic resonance imaging (MRI) to visualize CSVD, which included log-transformed white matter hyperintensities (log-WMH) volume and the presence (yes/no) of lacunes, cerebral microbleeds (CMB), or enlarged perivascular spaces (EPVS). Linear and logistic regression models were applied to examine the association between CSVD and each +10-mmHg increment in the office and ambulatory systolic BP measurements. Improvement in the fit of nested logistic models was assessed by the log-likelihood ratio and the generalized R(2) statistic. RESULTS: Office and ambulatory systolic BP measurements were related to log-WMH (β-correlation coefficients ≥0.08; P < 0.001). Lacunes and CMB were only associated with ambulatory systolic BP measurements (odds ratios [OR] ranged from 1.31 [95% confidence interval, 1.10-1.55] to 1.46 [1.17–1.84], P ≤ 0.003). Accounted for daytime systolic BP, both the 24-h (β-correlation, 0.170) and nighttime (β-correlation, 0.038) systolic BP measurements remained related to log-WMH. When accounted for 24-h or daytime systolic BP levels, the nighttime systolic BP retained the significant association with lacunes (ORs, 1.05–1.06; 95% CIs, ≥1.01 to ≤ 1.13), whereas the 24-h and daytime systolic BP levels were not associated with lacunes after adjustments for nighttime systolic BP (ORs, ≤ 0.88; 95% CI, ≥0.77 to ≤ 1.14). On top of covariables and office systolic BP, ambulatory systolic BP measurements significantly improved model performance (1.05% ≥ R(2) ≤ 3.82%). Compared to 24-h and daytime systolic BP, nighttime systolic BP had the strongest improvement in the model performance; for WMH (1.46 vs. 1.05%) and lacunes (3.06 vs. ≤ 2.05%). CONCLUSIONS: Twenty-four-hour and nighttime systolic BP were the more robust BP measurements associated with CSVD, but the nighttime systolic BP level had the strongest association. Controlling ambulatory BP levels might provide additional improvement in the prevention of CSVD.
format Online
Article
Text
id pubmed-9330602
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93306022022-07-29 Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements Melgarejo, Jesus D. Maestre, Gladys E. Gutierrez, Jose Thijs, Lutgarde Mena, Luis J. Gaona, Ciro Leendertz, Reinier Lee, Joseph H. Chávez, Carlos A. Calmon, Gustavo Silva, Egle Wei, Dongmei Terwilliger, Joseph D. Vanassche, Thomas Janssens, Stefan Verhamme, Peter Bos, Daniel Zhang, Zhen-Yu Front Neurol Neurology BACKGROUND: Twenty-four-hour and nighttime blood pressure (BP) levels are more strongly associated with cardiovascular risk than office or daytime BP measurements. However, it remains undocumented which of the office and ambulatory BP measurements have the strongest association and predictive information in relation to the presence of type I, or arteriolosclerosis type, cerebral small vessel diseases (CSVD). METHODS: A subset of 429 participants from the Maracaibo Aging Study [aged ≥40 years (women, 73.7%; mean age, 59.3 years)] underwent baseline brain magnetic resonance imaging (MRI) to visualize CSVD, which included log-transformed white matter hyperintensities (log-WMH) volume and the presence (yes/no) of lacunes, cerebral microbleeds (CMB), or enlarged perivascular spaces (EPVS). Linear and logistic regression models were applied to examine the association between CSVD and each +10-mmHg increment in the office and ambulatory systolic BP measurements. Improvement in the fit of nested logistic models was assessed by the log-likelihood ratio and the generalized R(2) statistic. RESULTS: Office and ambulatory systolic BP measurements were related to log-WMH (β-correlation coefficients ≥0.08; P < 0.001). Lacunes and CMB were only associated with ambulatory systolic BP measurements (odds ratios [OR] ranged from 1.31 [95% confidence interval, 1.10-1.55] to 1.46 [1.17–1.84], P ≤ 0.003). Accounted for daytime systolic BP, both the 24-h (β-correlation, 0.170) and nighttime (β-correlation, 0.038) systolic BP measurements remained related to log-WMH. When accounted for 24-h or daytime systolic BP levels, the nighttime systolic BP retained the significant association with lacunes (ORs, 1.05–1.06; 95% CIs, ≥1.01 to ≤ 1.13), whereas the 24-h and daytime systolic BP levels were not associated with lacunes after adjustments for nighttime systolic BP (ORs, ≤ 0.88; 95% CI, ≥0.77 to ≤ 1.14). On top of covariables and office systolic BP, ambulatory systolic BP measurements significantly improved model performance (1.05% ≥ R(2) ≤ 3.82%). Compared to 24-h and daytime systolic BP, nighttime systolic BP had the strongest improvement in the model performance; for WMH (1.46 vs. 1.05%) and lacunes (3.06 vs. ≤ 2.05%). CONCLUSIONS: Twenty-four-hour and nighttime systolic BP were the more robust BP measurements associated with CSVD, but the nighttime systolic BP level had the strongest association. Controlling ambulatory BP levels might provide additional improvement in the prevention of CSVD. Frontiers Media S.A. 2022-07-14 /pmc/articles/PMC9330602/ /pubmed/35911921 http://dx.doi.org/10.3389/fneur.2022.908260 Text en Copyright © 2022 Melgarejo, Maestre, Gutierrez, Thijs, Mena, Gaona, Leendertz, Lee, Chávez, Calmon, Silva, Wei, Terwilliger, Vanassche, Janssens, Verhamme, Bos and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Melgarejo, Jesus D.
Maestre, Gladys E.
Gutierrez, Jose
Thijs, Lutgarde
Mena, Luis J.
Gaona, Ciro
Leendertz, Reinier
Lee, Joseph H.
Chávez, Carlos A.
Calmon, Gustavo
Silva, Egle
Wei, Dongmei
Terwilliger, Joseph D.
Vanassche, Thomas
Janssens, Stefan
Verhamme, Peter
Bos, Daniel
Zhang, Zhen-Yu
Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements
title Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements
title_full Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements
title_fullStr Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements
title_full_unstemmed Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements
title_short Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements
title_sort subclinical magnetic resonance imaging markers of cerebral small vessel disease in relation to office and ambulatory blood pressure measurements
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330602/
https://www.ncbi.nlm.nih.gov/pubmed/35911921
http://dx.doi.org/10.3389/fneur.2022.908260
work_keys_str_mv AT melgarejojesusd subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT maestregladyse subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT gutierrezjose subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT thijslutgarde subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT menaluisj subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT gaonaciro subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT leendertzreinier subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT leejosephh subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT chavezcarlosa subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT calmongustavo subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT silvaegle subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT weidongmei subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT terwilligerjosephd subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT vanasschethomas subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT janssensstefan subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT verhammepeter subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT bosdaniel subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements
AT zhangzhenyu subclinicalmagneticresonanceimagingmarkersofcerebralsmallvesseldiseaseinrelationtoofficeandambulatorybloodpressuremeasurements